Skip to main content

Advertisement

Log in

Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patients

Langfristiges kosmetisches Ergebnis nach neoadjuvanter Radio‑/Chemotherapie bei lokal fortgeschrittenen Brustkrebspatientinnen

  • Original Article
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

Abstract

Background

Preoperative radiotherapy and chemoradiotherapy (PRT/PCRT) represent an increasingly used clinical strategy in different tumor sites. We have previously reported on a PRT/PRCT protocol in patients with locally advanced non-inflammatory breast cancer (LABC) with promising clinical results. However, concerns regarding a possible unfavorable influence on cosmesis still exist. Thus, the aim of the current study was to examine long-term cosmetic outcome in our series of LABC patients treated with PRT/PCRT followed by breast-conserving surgery (BCS) or mastectomy (ME).

Patients and methods

Of the 315 patients treated with PRT/PCRT in the years 1991 to 1999, 203 were still alive at long-term follow-up of mean 17.7 years (range 14–21). Thirty-seven patients were lost to follow-up and 58 patients refused to be contacted, which resulted in 107 patients (64 patients after BCS and 43 after mastectomy) being available and willing to undergo further cosmetic assessment. One patient had a complete response after PRT/PCRT and refused surgery. PRT/PCRT consisted of external beam radiation therapy (EBRT) with 50 Gy (5 × 2 Gy/week) to the breast and the supra-/infraclavicular lymph nodes combined with a consecutive electron boost or (in case of BCS) a 10-Gy interstitial brachytherapy boost with Ir-192 prior to EBRT. Overall, chemotherapy was administered either prior to RT or concomitantly in the majority of patients. BCS and mastectomy were performed with and without reconstruction. The cosmetic outcome was assessed by patient questionnaire, panel evaluation, and breast retraction assessment (BRA) score.

Results

Eighty percent of all BCS patients rated their overall cosmetic result as “excellent” or “good” as compared to 55.8% after mastectomy. Patient and panel ratings on cosmetic outcomes were similar between the two groups. No grade III or IV fibrosis were detected in any of the groups. The median BRA score after breast conserving surgery was 2.9.

Conclusion

PRT/PCRT is associated with low grades of fibrosis and a good to excellent long-term cosmetic outcome.

Zusammenfassung

Hintergrund

Die präoperative Radiotherapie und Chemoradiotherapie (PRT/PCRT) stellen eine zunehmend angewandte klinische Strategie bei verschiedenen Tumorentitäten dar. Wir haben bereits über ein PRT/PRCT-Protokoll bei Patientinnen mit lokal fortgeschrittenem nichtinflammatorischem Mammakarzinom (LABC) mit vielversprechenden klinischen Ergebnissen berichtet. Es bestehen jedoch immer noch Bedenken hinsichtlich eines möglichen ungünstigen Einflusses auf die Kosmetik. Ziel der aktuellen Studie war es daher, das langfristige kosmetische Ergebnis unserer Behandlungsserie von mit PRT/PCRT behandelten LABC-Patienten, die eine brusterhaltenden Operation (BCS) oder einer Mastektomie (ME) erhielten, zu untersuchen.

Patienten und Methoden

Von den 315 Patientinnen, die in den Jahren 1991 bis 1999 mit PRT/PCRT behandelt wurden, lebten noch 203 Patientinnen bei einer Langzeitbeobachtung von durchschnittlich 17,7 Jahren (Spanne 14–21 Jahre). Von den Patientinnen konnten 37 nicht mehr kontaktiert werden und 58 lehnten eine Kontaktaufnahme ab, was dazu führte, dass 107 Patientinnen (64 Patientinnen nach BCS und 43 nach ME) zur Verfügung standen und bereit waren, sich einer weiteren kosmetischen Beurteilung zu unterziehen. Eine Patientin hatte eine komplette pathologische Remission und verweigerte eine anschließende Operation. Die PRT/PCRT bestand aus einer externen Strahlentherapie (EBRT) mit 50 Gy (5 × 2 Gy/Woche) an der Brust und den supra-/infraklavikulären Lymphknoten, kombiniert mit einem konsekutiven Elektronenboost oder (bei BCS) einer interstitiellen Brachytherapie von 10 Gy mit Ir-192 vor EBRT. Insgesamt wurde die Chemotherapie entweder vor der RT oder bei der Mehrzahl der Patientinnen gleichzeitig verabreicht. Die BCS und ME wurden mit und ohne Rekonstruktion durchgeführt. Das kosmetische Ergebnis wurde anhand des Patientenfragebogens, der Einschätzung von Fachpersonal und der Bewertung der Asymmetrie der Brustwarzen (BRA) beurteilt.

Ergebnisse

Von allen BCS-Patientinnen bewerteten 80 % ihr gesamtes kosmetisches Ergebnis als „ausgezeichnet“ oder „gut“ im Vergleich zu 55,8 % nach ME. Die Bewertungen der Patientinnen und des Fachpersonals zu den kosmetischen Ergebnissen waren in beiden Gruppen ähnlich. In keiner der Gruppen wurde eine Fibrose Grad III oder IV festgestellt. Der mediane BRA-Score nach BCS betrug 2,9.

Schlussfolgerung

Eine PRT/PCRT ist mit niedrigen Fibrosegraden und einem guten bis hervorragenden kosmetischen Langzeitergebnis verbunden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

60 Co:

Cobalt 60

BCS:

Breast-conserving surgery

BCT:

Breast-conserving treatment

BRA:

Breast retraction assessment

DFS:

Disease-free survival

EBRT:

External beam radiation therapy

EORTC:

European Organisation for Research and Treatment of Cancer

G:

Grading

Gy:

Gray

HR:

Hazard ratio

HR+:

Hormone receptor positive

HR–:

Hormone receptor negative

IMRT:

Intensity modulated radiotherapy

Inv:

Investigator

LDF:

Latissimus dorsi flap

LENT-SOMA:

Late Effects of Normal Tissues—subjective, objective, management

LHRH:

Luteinizing hormone-releasing hormone

ME:

Mastectomy

MRM:

Modified radical ME

n. a.:

Not available

No:

Number

OS:

Overall survival

pCR:

Pathological complete response

PCRT:

Preoperative radiochemotherapy

PRT:

Preoperative radiotherapy

RR:

Risk ratio

RT:

Radiotherapy

SAS:

Statistical analysis system

References

  1. Budach W, Kammers K, Boelke E, Matuschek C (2013) Adjuvant radiotherapy of regional lymph nodes in breast cancer—A meta-analysis of randomized trials. Radiat Oncol 8:267

    Article  PubMed  PubMed Central  Google Scholar 

  2. Krug D, Baumann R, Budach W et al (2018) Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer: A systematic review. Strahlenther Onkol 194:607–618

    Article  PubMed  Google Scholar 

  3. Krug D, Baumann R, Budach W et al (2018) Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment. Strahlenther Onkol 194:797–805

    Article  PubMed  Google Scholar 

  4. Piroth MD, Baumann R, Budach W et al (2019) Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention. Strahlenther Onkol 195:1–12

    Article  PubMed  Google Scholar 

  5. Kaidar-Person O, Kuten A, Belkacemi Y (2014) Primary systemic therapy and whole breast irradiation for locally advanced breast cancer: A systematic review. Crit Rev Oncol Hematol 92:143–152

    Article  PubMed  Google Scholar 

  6. Pazos M, Corradini S, Dian D et al (2017) Neoadjuvant radiotherapy followed by mastectomy and immediate breast reconstruction: An alternative treatment option for locally advanced breast cancer. Strahlenther Onkol 193:324–331

    Article  PubMed  Google Scholar 

  7. Gerlach B, Audretsch W, Gogolin F et al (2003) Remission rates in breast cancer treated with preoperative chemotherapy and radiotherapy. Strahlenther Onkol 179:306–311

    Article  PubMed  Google Scholar 

  8. Matuschek C, Bolke E, Roth SL et al (2012) Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission: Results of a multivariate analysis. Strahlenther Onkol 188:777–781

    Article  CAS  PubMed  Google Scholar 

  9. Cocquyt VF, Blondeel PN, Depypere HT et al (2003) Better cosmetic results and comparable quality of life after skin-sparing mastectomy and immediate autologous breast reconstruction compared to breast conservative treatment. Br J Plast Surg 56:462–470

    Article  PubMed  Google Scholar 

  10. Coles CE, Brunt AM, Wheatley D, Mukesh MB, Yarnold JR (2013) Breast radiotherapy: Less is more? Clin Oncol (R Coll Radiol) 25:127–134

    Article  CAS  Google Scholar 

  11. Dujmovic A, Marcinko D, Bulic K, Kisic H, Dudukovic M, Mijatovic D (2017) Quality of life and depression among female patients undergoing surgical treatment for breast cancer: A prospective study. Psychiatr Danub 29:345–350

    Article  PubMed  Google Scholar 

  12. Nestle-Kramling C, Bolke E, Budach W, Andree C (2016) Breast reconstruction after neoadjuvant radio chemotherapy: Review and personal technique IDEAL concept REV-EJMR-D-15-00268. Eur J Med Res 21:24

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Roth SL, Audretsch W, Bojar H, Lang I, Willers R, Budach W (2010) Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer: Survival advantage in cT2 category by neoadjuvant radiochemotherapy. Strahlenther Onkol 186:299–306

    Article  PubMed  Google Scholar 

  14. Harris JR, Levene MB, Svensson G, Hellman S (1979) Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 5:257–261

    Article  CAS  PubMed  Google Scholar 

  15. Pezner RD, Patterson MP, Hill LR et al (1985) Breast retraction assessment: An objective evaluation of cosmetic results of patients treated conservatively for breast cancer. Int J Radiat Oncol Biol Phys 11:575–578

    Article  CAS  PubMed  Google Scholar 

  16. Pezner RD, Patterson MP, Hill LR, Vora NL, Desai KR, Lipsett JA (1985) Breast retraction assessment. Multiple variable analysis of factors responsible for cosmetic retraction in patients treated conservatively for stage I or II breast carcinoma. Acta Radiol Oncol 24:327–330

    Article  CAS  PubMed  Google Scholar 

  17. Van Limbergen E, van der Schueren E, Van Tongelen K (1989) Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system. Radiother Oncol 16:159–167

    Article  PubMed  Google Scholar 

  18. Mornex F, Pavy JJ, Denekamp J, Bolla M (1997) Scoring system of late effects of radiations on normal tissues: The SOMA-LENT scale. Cancer Radiother 1:622–668

    Article  CAS  PubMed  Google Scholar 

  19. Rubin P, Constine LS 3rd, Fajardo LF, Phillips TL, Wasserman TH (1995) Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 35(1):9–10

    Article  CAS  PubMed  Google Scholar 

  20. Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH (1995) Overview. Late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31:1041–1042

    Article  CAS  PubMed  Google Scholar 

  21. Chang EI, Ly DP, Wey PD (2007) Comparison of aesthetic breast reconstruction after skin-sparing or conventional mastectomy in patients receiving preoperative radiation therapy. Ann Plast Surg 59:78–81

    Article  CAS  PubMed  Google Scholar 

  22. Hultman CS, Daiza S (2003) Skin-sparing mastectomy flap complications after breast reconstruction: Review of incidence, management, and outcome. Ann Plast Surg 50:249–255 (discussion 255)

    Article  PubMed  Google Scholar 

  23. Selber JC, Kurichi JE, Vega SJ, Sonnad SS, Serletti JM (2006) Risk factors and complications in free TRAM flap breast reconstruction. Ann Plast Surg 56:492–497

    Article  CAS  PubMed  Google Scholar 

  24. Krueger EA, Wilkins EG, Strawderman M et al (2001) Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys 49:713–721

    Article  CAS  PubMed  Google Scholar 

  25. Ascherman JA, Hanasono MM, Newman MI, Hughes DB (2006) Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg 117:359–365

    Article  CAS  PubMed  Google Scholar 

  26. Berbers J, van Baardwijk A, Houben R et al (2014) ‘Reconstruction: Before or after postmastectomy radiotherapy?’ A systematic review of the literature. Eur J Cancer 50:2752–2762

    Article  PubMed  Google Scholar 

  27. Nava MB, Pennati AE, Lozza L, Spano A, Zambetti M, Catanuto G (2011) Outcome of different timings of radiotherapy in implant-based breast reconstructions. Plast Reconstr Surg 128:353–359

    Article  CAS  PubMed  Google Scholar 

  28. Baltodano PA, Flores JM, Kone L et al (2014) Abstract 120: Neoadjuvant radiotherapy is not associated with increased post-mastectomy/reconstruction morbidity events: A critical analysis of 85,851 patients from the ACS-NSQIP database. Plast Reconstr Surg 133:135–136

    Article  PubMed  Google Scholar 

  29. Mukai H, Watanabe T, Mitsumori M et al (2013) Final results of a safety and efficacy trial of preoperative sequential chemoradiation therapy for the nonsurgical treatment of early breast cancer: Japan Clinical Oncology Group Study JCOG0306. Oncology 85:336–341

    Article  CAS  PubMed  Google Scholar 

  30. Touboul E, Lefranc JP, Blondon J et al (1997) Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer. Radiother Oncol 42:219–229

    Article  CAS  PubMed  Google Scholar 

  31. Semiglazov VF, Topuzov EE, Bavli JL et al (1994) Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb–IIIa breast cancer. Ann Oncol 5:591–595

    Article  CAS  PubMed  Google Scholar 

  32. Shanta V, Swaminathan R, Rama R, Radhika R (2008) Retrospective analysis of locally advanced noninflammatory breast cancer from Chennai, South India, 1990–1999. Int J Radiat Oncol Biol Phys 70:51–58

    Article  PubMed  Google Scholar 

  33. Mukesh MB, Barnett GC, Wilkinson JS et al (2013) Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5‑year results confirm superior overall cosmesis. J Clin Oncol 31:4488–4495

    Article  PubMed  Google Scholar 

  34. Keller LM, Sopka DM, Li T et al (2012) Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: The Fox Chase Cancer Center experience. Int J Radiat Oncol Biol Phys 84:881–887

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

C. Matuschek, C. Nestle-Kraemling, E. Bölke, and W. Budach had the idea, coordinated the work, and wrote parts of the manuscript. J. Haussmann did the literature research, prepared the data for analysis, and wrote parts of the manuscript. K. Kammers and J. Haussmann did the statistical analysis. S. Wollandt, V. Speer, F.J. Djiepmo Njanang, P.A. Gerber, K. Orth, E. Ruckhaeberle, T. Fehm, S. Corradini, G. Lammering, S. Mohrmann, S. Roth wrote parts of the manuscript. W. Audretsch operated all patients. J. Haussmann contributed significantly to the discussion on the interpretation of the results. C. Matuschek, J. Haussmann, and P.A. Gerber prepared the figures and tables. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Edwin Bölke.

Ethics declarations

Conflict of interest

C. Matuschek, C. Nestle-Kraemling, J. Haussmann, E. Bölke, S. Wollandt, V. Speer, F.J. Djiepmo Njanang, B. Tamaskovics, P.A. Gerber, K. Orth, E. Ruckhaeberle, T. Fehm, S. Corradini, G. Lammering, S. Mohrmann, W. Audretsch, S. Roth, K. Kammers, and W. Budach declare that they have no competing interests.

Ethical standards

The study was approved by the local ethics committee (No.: 4070).

Additional information

The authors C. Matuschek and C. Nestle-Kraemling contributed equally to the manuscript.

The work is a part of the thesis of S. Wollandt and V. Speer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matuschek, C., Nestle-Kraemling, C., Haussmann, J. et al. Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patients. Strahlenther Onkol 195, 615–628 (2019). https://doi.org/10.1007/s00066-019-01473-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-019-01473-2

Keywords

Schlüsselwörter

Navigation